-
1
-
-
12944271053
-
Cancer statistics, 2003
-
Jemal A, Murray T, Samels A, et al. Cancer statistics, 2003. CA Cancer J Clin. 2005;55(1):10-30.
-
(2005)
CA Cancer J Clin
, vol.55
, Issue.1
, pp. 10-30
-
-
Jemal, A.1
Murray, T.2
Samels, A.3
-
2
-
-
0032543663
-
Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer
-
Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med. 1998;338(25):1798-1804.
-
(1998)
N Engl J Med
, vol.338
, Issue.25
, pp. 1798-1804
-
-
Brizel, D.M.1
Albers, M.E.2
Fisher, S.R.3
-
3
-
-
0031925723
-
Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study
-
Wendt TG, Garbenhauer CC, Rodel CM, et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol. 1998;16(4):1318-1324.
-
(1998)
J Clin Oncol
, vol.16
, Issue.4
, pp. 1318-1324
-
-
Wendt, T.G.1
Garbenhauer, C.C.2
Rodel, C.M.3
-
4
-
-
0034681783
-
MACH-NC Collaborative Group: Meta-Analysis of Chemotherapy on Head and Neck Cancer. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data
-
Pignon JP, Bourhis J, Domenge C, et al; MACH-NC Collaborative Group: Meta-Analysis of Chemotherapy on Head and Neck Cancer. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet. 2000;355(9208):949-955.
-
(2000)
Lancet
, vol.355
, Issue.9208
, pp. 949-955
-
-
Pignon, J.P.1
Bourhis, J.2
Domenge, C.3
-
5
-
-
33644983568
-
Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: Results from a single institution
-
Adelstein DJ, Saxton JP, Rybicki LA, et al. Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: results from a single institution. J Clin Oncol. 2006;24(7):1064-1071.
-
(2006)
J Clin Oncol
, vol.24
, Issue.7
, pp. 1064-1071
-
-
Adelstein, D.J.1
Saxton, J.P.2
Rybicki, L.A.3
-
6
-
-
0025735629
-
The dendritic cell system and its role in immunogenicity
-
Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol. 1991;9:271-296.
-
(1991)
Annu Rev Immunol
, vol.9
, pp. 271-296
-
-
Steinman, R.M.1
-
9
-
-
0035889647
-
Active immunization against cancer with dendritic cells: The near future
-
Steinman RM, Dhodapkar M. Active immunization against cancer with dendritic cells: the near future. Int J Cancer. 2001;94(4):459-473.
-
(2001)
Int J Cancer
, vol.94
, Issue.4
, pp. 459-473
-
-
Steinman, R.M.1
Dhodapkar, M.2
-
10
-
-
18844385431
-
Allogenic tumor hybrid cells as basis for cancer vaccine
-
Lee WT, Shimizu K, Kuriyama H, Tanaka H, Kjaergaard J, Shu S. Allogenic tumor hybrid cells as basis for cancer vaccine. Otolaryngol Head Neck Surg. 2005;132(5):755-764.
-
(2005)
Otolaryngol Head Neck Surg
, vol.132
, Issue.5
, pp. 755-764
-
-
Lee, W.T.1
Shimizu, K.2
Kuriyama, H.3
Tanaka, H.4
Kjaergaard, J.5
Shu, S.6
-
11
-
-
0347753896
-
Electrofusion of syngeneic dendritic cells and tumor generates potent therapeutic vaccine
-
Kjaergaard J, Shimizu K, Shu S. Electrofusion of syngeneic dendritic cells and tumor generates potent therapeutic vaccine. Cell Immunol. 2003;225(2):65-74.
-
(2003)
Cell Immunol
, vol.225
, Issue.2
, pp. 65-74
-
-
Kjaergaard, J.1
Shimizu, K.2
Shu, S.3
-
12
-
-
0034835565
-
Characterization of a spontaneously arising murine squamous cell carcinoma (SCC VII) as a prerequisite for head and neck cancer immunotherapy
-
Khurana D, Martin EA, Kasperbauer J. Characterization of a spontaneously arising murine squamous cell carcinoma (SCC VII) as a prerequisite for head and neck cancer immunotherapy. Head Neck. 2001;23(10):899-906.
-
(2001)
Head Neck
, vol.23
, Issue.10
, pp. 899-906
-
-
Khurana, D.1
Martin, E.A.2
Kasperbauer, J.3
-
13
-
-
33847068762
-
Mechanism of third signals provided by IL-12 and OX-40R ligation in eliciting therapeutic immunity following dendritic-tumor fusion vaccination
-
Kuriyama H, Watanabe S, Kjaergaard J, et al. Mechanism of third signals provided by IL-12 and OX-40R ligation in eliciting therapeutic immunity following dendritic-tumor fusion vaccination. Cell Immunol. 2006;243(1):30-40.
-
(2006)
Cell Immunol
, vol.243
, Issue.1
, pp. 30-40
-
-
Kuriyama, H.1
Watanabe, S.2
Kjaergaard, J.3
-
14
-
-
21644443247
-
Therapeutic vaccine generated by electrofusion of dendritic cells and tumour cells
-
Kuriyama H, Shimizu K, Lee W, et al. Therapeutic vaccine generated by electrofusion of dendritic cells and tumour cells. Dev Biol (Basel). 2004;116:169-178.
-
(2004)
Dev Biol (Basel)
, vol.116
, pp. 169-178
-
-
Kuriyama, H.1
Shimizu, K.2
Lee, W.3
-
15
-
-
2342627345
-
A dendritic cell based hybrid cell vaccine generated by electrofusion for immunotherapy strategies in HNSCC
-
Weise JB, Maune S, Gorogh T, et al. A dendritic cell based hybrid cell vaccine generated by electrofusion for immunotherapy strategies in HNSCC. Auris Nasus Larynx. 2004;31(2):149-153.
-
(2004)
Auris Nasus Larynx
, vol.31
, Issue.2
, pp. 149-153
-
-
Weise, J.B.1
Maune, S.2
Gorogh, T.3
|